199 related articles for article (PubMed ID: 16554444)
1. Clinical pharmacology of the appeals and exception process: the interface of the patient, physician, and insurance company to assure appropriate care under Medicare Part D.
Blum RS
J Clin Pharmacol; 2006 Apr; 46(4):394-7. PubMed ID: 16554444
[TBL] [Abstract][Full Text] [Related]
2. Navigating Medicare drug coverage: Part B vs. Part D.
Piper KB
Manag Care; 2006 Jul; 15(7 Suppl 3):17-20. PubMed ID: 16898056
[TBL] [Abstract][Full Text] [Related]
3. Medicare Part D: exceptions and appeals process.
Lace DA
Manag Care; 2006 Jul; 15(7 Suppl 3):13-7. PubMed ID: 16898055
[TBL] [Abstract][Full Text] [Related]
4. Got Medicare? What people living with HIV need to know about the new Medicare drug benefit - "Part D" - starting January 1, 2006.
Subways S
AIDS Treat News; 2005 Sep; (415):6-8. PubMed ID: 16276606
[TBL] [Abstract][Full Text] [Related]
5. Perspectives. E-prescribing, formularies play big roles in Rx bill. 2.
Med Health; 2003 Dec; 57(45):1, 7-8. PubMed ID: 14723167
[No Abstract] [Full Text] [Related]
6. No consensus on Medicare issues, malpractice reform, patients' bill of rights.
Van Koevering M
Healthplan; 2002; 43(5):8-10, 12. PubMed ID: 12387145
[No Abstract] [Full Text] [Related]
7. The Patients' Bill of Rights and Medicare prescription drug benefits.
Rubin RJ
J Med Pract Manage; 2001; 17(2):59-60. PubMed ID: 11680136
[No Abstract] [Full Text] [Related]
8. The new Medicare prescription drug benefit: important issues for physician practices.
Falk R; Stranne S
J Med Pract Manage; 2005; 21(3):133-7. PubMed ID: 16471382
[TBL] [Abstract][Full Text] [Related]
9. Medicare Catastrophic Coverage Act, 1988. Part 2.
Mehl B
Hosp Pharm; 1989 Aug; 24(8):645-8. PubMed ID: 10303773
[No Abstract] [Full Text] [Related]
10. The devil is in the D tales. While politicians squabble, physicians and pharmacists are forced to advise seniors on Part D despite being unprepared.
Lubell J; DoBias M
Mod Healthc; 2006 May; 36(20):6-7, 16, 1. PubMed ID: 16752856
[TBL] [Abstract][Full Text] [Related]
11. CMS rules on employers, formularies, PPOs raise concerns.
Med Health; 2004 Sep; 58(34):2-3. PubMed ID: 15487559
[No Abstract] [Full Text] [Related]
12. Prediction of Medicare drug formulary drugs for treatment of overactive bladder.
Grocela JA; Kanji A; Ternullo J
J Urol; 2006 Jul; 176(1):252-5; discussion 255-6. PubMed ID: 16753413
[TBL] [Abstract][Full Text] [Related]
13. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109
[TBL] [Abstract][Full Text] [Related]
14. Tiers reach new heights under Part D.
Adler D
Manag Care; 2006 Mar; 15(3):63-4. PubMed ID: 16604930
[No Abstract] [Full Text] [Related]
15. Access to Medicare Part D gap coverage more scarce in 2007.
Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
[No Abstract] [Full Text] [Related]
16. Medicare prescription drug plans: the impact on physician practice.
Marable S
Med Health R I; 2006 Jan; 89(1):39-40. PubMed ID: 16519205
[No Abstract] [Full Text] [Related]
17. Ripe for scrutiny. In wake of probes, PBMs may draw extra attention.
Fong T
Mod Healthc; 2005 Nov; 35(48):28. PubMed ID: 16617722
[No Abstract] [Full Text] [Related]
18. Stats & facts. A team of health bills at bat: when will they get to play?
Manag Care Interface; 2002 May; 15(5):84-5. PubMed ID: 12024876
[No Abstract] [Full Text] [Related]
19. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
[TBL] [Abstract][Full Text] [Related]
20. Medicare muddle. Rx drug benefit confuses both enrollees, provider.
DoBias M
Mod Healthc; 2006 Jan; 36(1):8-9. PubMed ID: 16447806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
